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Abstract 
Background: Control of blood acids and bases can help prevent many 
potentially life-threatening disorders in end stage renal disease (ESRD) 
patients. Aim of this study was to assess the effect of acid-base balance on 
cytokines serum levels and short-term outcomes in kidney transplant 
recipients.  
Materials and Methods: In this randomized clinical trial study, 40 patients 
with end-stage renal disease aged 18 to 70 who had undergone a kidney 
transplant from a living donor in Modarres hospital during 2016-2017 were 
included. The primary outcomes measured in this study were sera levels of 
cytokine such as IL-2, IL-10, IFN-γ and BUN and Cr serum after the 
treatment of acidosis in kidney transplant recipients.  
Results: Mean±SD of the patient’s age was 42±12.6 years. Results showed 
that there is a significant difference in means of IL-2, IL-10, and IFN-γ 
between the intervention and control groups over the time (for all p<0.05). 
We also found that correction of acidosis occurred with reduces of IFN-γ to 
-1.74 in the intervention group compared to the group receiving saline 
(P=0.011); and reduction for IL-2 was -1.37 (p=0.025). The concentration 
of anti-inflammatory cytokine of IL-10 was increased to 2.85 (P<0.001).  
Conclusion: The results clearly suggest that correction of acidosis in renal 
transplant patients during surgery helps improve the performance of allograft 
in the short run; however, more studies are recommended, taking into account 
the long-term and short-term effects of this intervention.  
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Nowadays kidney transplant as the main 
treatment for end-stage renal failure, has become one 
of the most common types of transplant and hence a 
big step in improving the life quality and expectancy. 
In the history of treatment, the life expectancy of 
post-transplant patients has greatly increased and the 
percentage of successful transplants continues to 
rise (1). From the beginning stages of kidney 
transplant therapy to now, there have 
been many changes in anesthesia techniques 
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and surgical methods as well as post-transplant 
aftercare, which have altogether helped improve 
longevity of the graft (2). Given the delicacy and 
importance of anesthesia as well as its important role 
in the success of transplant, there has been a growing 
body of literature on this treatment and any attempt to 
improve the quality of the anesthesia could play a 
major role in the survival of the patients (3). Patients 
with kidney failure suffer from chronic metabolic 
acidosis, hyponatremia, hypokalemia, and 
hyperchloraemia, which can potentially cause certain 
arrhythmias including bradycardia, heart block, 
hypotension, neuromuscular disorders as well as 
dyspnea and respiratory failure. In this regard, the 
control of acids and bases help prevent many 
potentially life-threatening disorders in these patients 
(4, 5). Given the importance of immunological factors 
in the transplant success or rejection, it is required to 
perform certain immunological compatibility 
experiments before transplantation, which is normally 
done in the transplant unit. The measurement of 
serum cytokines is helpful in evaluating the 
immunological status of the patient and assessing the 
effects of acidosis correction on immunological 
parameters. For example TNF-  , IFN-  and IL-2 are 
important mediators of transplant rejection. IL-2 is 
essential in reproduction of T cells and production of 
efficient CTLs. IFN-  plays the central role in the 
formation of delayed-type hypersensitivity response, 
macrophages infiltration into connective tissue, 
activation of them and conversion of them into 
destructive cells (6). The IL-2 and IFN-γ are among 
the cytokines reinforcing the cellular immune 
response, and their increased serum levels suggest 
poor prognosis of the transplantation. This is the fact 
while IL-10 represents an anti-inflammatory cytokine 
and inhibits the cellular immune response and, at the 
same time, increases the probability of a successful 
transplantation (7). The purpose of the present study 
was to evaluate the effect of acid-base balance on 
cytokines serum levels and short-term outcomes in 




The present study was a randomized clinical 
trial with parallel design performed with a 1-1 ratio 
for the intervention and placebo group in Tehran 
Shahid Modarres Hospital (is the only governmental 
facility in north-western Tehran). The study 
population consisted of all patients with end-stage 
renal disease who were candidate for a kidney 
transplant from a living donor, had visited the kidney 
transplant unit of the hospital from late April in 2016 
to early February in 2017, and had undergone a 
treatment with sodium bicarbonate (intervention 
group) or placebo (control group). The study 
participants included 40 patients with end-stage renal 
disease aged 18 to 70 who had undergone a kidney 
transplant from a living donor. We used a 
probabilistic sampling strategy for selection the 
included participants. To do this, a simple random 
sampling was considered by using random digit table.  
The study inclusion criteria were: A. ASA 
Class I – II, B. Age range between 18 and 70 years 
and consent to participate in the study. The exclusion 
criteria were: A. Patients with end-stage 
cardiovascular problems, B. Metabolic acidosis with 
pH less than 7.15, C. Operation duration more than 3 
hours, D. Body temperature less than 35 or greater 
than 38.5°C axilla before or during the operation, E. 
The need for blood transfusions during the operation, 
F. age over 70 or under 18 years, G. kidney transplant 
from a nonliving donor, H. a history of cancer and 
immunological diseases and immune modulatory 
medications. 
Balanced block randomization techniques were 
used in the present study to randomly assign the 
participants in two intervention and control groups. 
Since blocking was done in 4 units in this study, a 
series of the random numbers 1 to 6 were produced 
using STATA to reach the desired sample size. Given 
that there are in total 6 states to arrange two subjects’ 
in 4 blocks, if the number obtained were more than 6, 
the next number was produced without considering it. 
The sequences of balanced block randomization were 
obtained and put in sealed envelopes numbered with a 
5-digit serial number by a third person who was not 
involved in the study design. All the envelopes (42 
persons) had a random 5-digit serial number and were 
immediately opened after completion of the basic 
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information and tests of the subjects, allocating them 
to intervention group (receiving sodium bicarbonate) 
and placebo group (normal saline). The primary 
outcomes measured in this study were changes of 
serum cytokine such as IL-2, IL-10, IFN-γ and BUN 
and Cr serum after the treatment of acidosis in kidney 
transplant recipients. The baseline clinical and 
demographic data of the patient such as age, sex, 
weight, time elapsed since the last hemodialysis, start 
time of base ESRD and ABG, the ABG when opening 
the clamp and registration of TOF from the end of the 
induction to the end of operation were all entered in 
the patient's information form.  
Treatment of metabolic acidosis 
The study was conducted as follows: before 
induction of anesthesia, a catheter no.18 was 
implanted for fluids and medication. Invasive 
monitoring of blood pressure was performed under 
local anesthesia after Allen's test using an artery 
catheter no.20 through the radial artery of the 
nondominant hand. The same catheter was used to 
take arterial blood samples at the beginning of 
operation and on opening the clamps. First, the 
patients were preoxygenated with 100% oxygen for 3 
minutes; then, based on a medical indication, 
midazolam with a dosage of 0.02 mg per kg and 
fentanyl 2μ/Kg were used. For induction of 
anesthesia, thiopental sodium with a dosage of 5 mg 
per kg was used. For muscle relaxation, atracurium 
with a dosage of 0.5 mg per kg was injected slowly. 
For maintenance of anesthesia, isoflurane with a 
dosage of 0.6-1% was used together with nitrous 
oxide at a ratio of 50%. During operation, if 
necessary, additional dosages of Atracurium were 
used. It is noteworthy that the last dose of Atracurium 
was administered while opening the clamp. After 
induction, central venous line was implanted through 
the right jugular vein. During the operation, the 
central venous pressure (CVP) was obtained at 10-12 
cmH2O and the patient's temperature was kept 
constant at 36°C and the patients in both groups were 
administered IV Lasix with the same dosage of 3 mg 
per kg and intravenous mannitol with a dosage of 0.5 
g per kg. During this process, none of the patients 
included in the study required any blood infusion. 
Similarly, saline fluid at a rate of 50 ml per kilogram 
of body weight was used in all cadaver donors. 
Arterial blood samples of all the subjects were sent to 
the laboratory to analyze Arterial pH, arterial 
bicarbonate (HCO3), BE (Base Excess) and Pressure 
of Arterial carbon dioxide (PaCO2) after induction of 
anesthesia. Other blood samples were sent to the 
laboratory on opening the clamps. During the first 
week after transplantation, BUN, Cr and 24-hour 
urine volume were measured and the blood samples 
were taken and sent to immunology laboratory to 
check for the pre-induction immunologic markers 
before induction and once after opening the clamps. 
Blood samples and serum were taken from all the 
study participants at appropriate times (before 
correction of acidosis, after correction of acidosis and 
7 days after operation) to measure the cytokines (IL-
2, IL-10, IFN-γ). 
The cytokines were measured using ELISA 
according to the instructions of the manufacturer's kit 
in the Laboratory of Department of Immunology, 
Shahid Beheshti University of Medical Sciences. A 
sample size of 21 patients in each group will be 
sufficient to detect a clinically important difference 
between the intervention and control group, using a 
two-tailed t-test of the difference between means, a 
power of 80%, and a significance level of 5%. The 
calculation is based on the assumption that the 




Levels of IFN γ, IL-2, and IL-10 in serum were 
measured using specific ELISA kits (Mabtech, Nacka 
Strand, Sweden), according to the manufacturer’s 
instructions. All measurements were carried out in 
duplicates. OPD was used as chromogenic substrates 
for horseradish peroxidase (HRP). Color intensity in 
samples/standard wells was measured at 492 nm 
using an Anthos 2020 microplate reader (Anthos, 
Wals, Austria). Values of each protein of interest in a 
sample were calculated by extrapolation from 
standard curves generated in parallel with kit-
provided standards. The level of sensitivity of the kits 
was 4-400 pg ml-1 for IFNγ, / IL-2 and 2-200 pg ml-1 
for IL-10. Furthermore, to prevent the information 
bias due to measurement error, all the devices are 
calibrated regularly.  
Statistical analysis 
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Continuous baseline demographic and clinical 
data are presented as mean ± standard deviation and 
grouped data as frequencies and percentages. Chi-
square test or Fisher’s exact test were used to 
determine the independence of the two categorical 
variables. Repeated measures of ANOVA were 
employed to investigate the mean differences of 
immune factors such as IL-2, IL-10 and IFN-γ 
between the groups over the time. To investigate the 
association between the treatment of metabolic 
acidosis and changes in serum Cr and BUN as well as 
immune factors such as IL-2, IL-10 and IFN-γ, the 
generalized estimation equation (GEE) method was 
undertaken.  The GEE is a widely used estimation 
method for marginal (i.e., population-averaged) 
modeling of repeated data. In brief, GEEs use the 
generalized linear model to estimate more efficient 
and unbiased regression parameters relative to 
ordinary least squares regression, in part because they 
permit specification of a working correlation matrix 
that accounts for the form of within-subject 
correlation of responses on dependent variables of 
many different distributions, including normal, 
binomial, and Poisson (8). All analyses were done 
using STATA statistical software (version 13MP). 
Ethical committee of Shahid Beheshti 
University of Medical Sciences 
(IR.SBMU.RAM.REC.1394.390;IRCT201509271220
3N4) approved this study. 
Results 
In the present study, we used data from 40 
ESRD patients candidate for receiving a kidney 
transplant from a living donor visiting Shahid 
Modarres Hospital in Tehran in 2016. As the figure 
below shows, finally and after excluding, in each 
group, 15 people failing to meet the inclusion criteria 
and 2 more ones who were lost to follow up, 20 
patients were examined and analyzed. 
In this study, the mean and standard deviation 
of age of the patients was 42±12.6 years. Of those 
examined, 29 ones (72.5%) were male and the rest 
were females (11 participants equivalent to 27.5%), 
respectively. The basic clinical information for the 
subjects in both groups is presented in Table 1. 
The independent t-test determining the 
difference of the mean serum creatinine between the 
two groups shows that from the first to sixth day, 
there is no significant difference between the mean 
serum creatinine in the two groups and that the 
difference was observed only on the seventh day (P = 
0.038). 
In this study, generalized estimation equations 
models (GEE) was used to evaluate the effect of 
treatment on outcomes of creatinine and BUN 
concentrations in serum. The models are presented in 
Table 2.  
The results showed that, the treatment of 
patient's acidosis did not affect serum creatinine 
levels. In other words, although the decrease in serum 
creatinine over time is statistically significant (p 
<0.001), this reduction is not attributable to the 
treatment of acidosis in kidney-transplant patients and 
there was no difference in the creatinine reduction 
between the intervention and control group. The 
results also show that correction of acidosis in kidney-
transplant patients resulted in a significant reduction 
in BUN serum levels in the intervention group 
compared to the control group (Coefficient= -0.25, 
95% CI:-0.5, -0.01). It should be noted, however, that 
the interaction effects between treatment and time 
were also significant and this means that treatment at 
different times would have different effects. 
Similarly, on investigating 24-hour urine volume 
within 7 days after transplantation in the intervention 
group (treatment of acidosis with bicarbonate) and 
control group (saline), the results of independent t-test 
showed that there was no statistically significant 
difference in average urine output between the control 
group (7870±478cc) and the intervention group 
(6973±445mL) (P =0.17). It should also be said that, 
following the investigation of the first-to-seventh-day 
urinary output in the two groups, the urine output was 
within the normal range in all the days except for the 
first day (due to intense hydration) and no statistical 
difference was observed (p> 0.05). Figure 2 shows the 
changes in the mentioned outcomes during 7 days 
after transplantation. 
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The repeated measures of ANOVA showed 
that there is a significant difference in means of IL-2, 
IL-10, and IFN-γ between the intervention and control 
groups over the time (Table 3). Also, the mean 
changes of the factors under study over time and 
following the treatment of acidosis were statistically 
significant, in a way that with respect to the factors 
IFN-γ and IL-2, these changes were decremental in 
the intervention group and fairly incremental in the 
control group, while the changes of the factors IL-
10 were contrary to those above. In all the models 
above, Mauchly's Test of Sphericity was meaningful; 
accordingly, Greenhouse-Geisser statistic was used. 
The changes of the three factors examined are 
shown in Figure 3. In this figure, the time 1 represents 
that before the transplant, the time 2 represents the 
first day after the transplant and the time 3 represents 
the seventh day after the transplant. 
For more tangible results in this study, GEE 
modeling approach was used to evaluate the effect of 
treatment on immunological factors. The results are 
given in Table 4. The results show that the time factor 
and its interaction with the type of treatment has a 
significant impact on the outcome under study and 
this means that the treatment has different effects in 
different times (the P interaction value is < 0.001 for 
all outcomes as shown in Table 4). 
The table shows that correction of acidosis in 
 
Figure 1. Flowchart of the studied participants. 
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patients reduces the IFN-γ by a factor of -1.74 in the 
intervention group compared to the group receiving 
saline (P=0.011). Also, the results showed that the 
levels of IL-2 was decreased after the treatment by a 
factors of -1.37 in intervention group compared to 
control group (p=0.025). The concentration of anti-
inflammatory cytokine of IL-10 was incremental by a 
factor of 2.85 in intervention group compared to 
control group (P<0.001). 
Discussion 
The results of this study indicate that treatment 
of metabolic acidosis during the operation in patients 
undergoing kidney transplantation is effective in 
improving the outcome of transplant and the 
performance of kidney in these patients. In addition, it 
can enhanced in terms of functional factors, including 
BUN serum and the factors linked with the cellular 
immunity of the transplant, including the cytokines 
IL-2, IL-10, IFN-γ.  
In the past two decades, the short-term 
outcomes of transplant have considerably improved, 
Table 1: Baseline characteristics and clinical data. 
 
Baseline Variables Intervention group Control group 
Mean (SD) Mean (SD) 
Arterial PH 7.29±0.09 7.30±0.07 
Arterial HCO3 (mmol/l) 16.4±4.1 16.6±2.71 
Arterial PaCO2 (mmol/l) 32.3±7.3 30.1±3.73 
Base excess (mEq/l) -10.6±4.29 -8.35±3 
BUN(mg/dl) 72.8±24.3 85±27.3 
Cr(mg/dl) 3.54±1.48 3.9±1.56 
IFN-γ(pg/ml) 8.41 (7.09-11.82) 9.14 (8.23-10.7) 
IL-10 (pg/ml) 5.75 (3.51-9.17) 3.83 (2.71-7.84) 
IL-2 (pg/ml) 7.34 (5.69- 7.88) 6.94( 5.73-8.15) 
 
Table 2: Results for the model of generalized equations structural analysis for investigation of the effects of acidosis 
treatment on Cr and BUN outcomes. 
 
Outcomes Variables Coefficient,% 95 CI P-value 
Cr Group -0.009 (-0.26, 0.24) 0.93 
Time -0.15 (-0.18, -0.12) <0.001 
Interaction * -0.015 (-0.05, -0.02) 0.42 
BUN Group -0.25 (-0.5, -0.01) 0.041 
Time -0.08 (-0.11, -0.05) <0.001 
Interaction 0.049 (0.01, 0.08) 0.013 
 
*Group time 
Table 3: Results of repeated measures of ANOVA on evaluating the effects of acidosis treatment on outcomes IL-2, 
IL-10, IFN-γ. 
 
Factors   Mean square F P value 
IFN-γ Group 91.59 6.29 0.017 
Factor 8.6 3.8 0.041 
Group * Factor 82.4 36.3 <0.001 
IL-2 Group 56.84 4.9 0.033 
Factor 9.3 5.1 0.008 
Group * Factor 32.1 17.5 <0.001 
IL-10 Group 245.01 12:54 0.001 
Factor 25.1 6.85 0.002 
Group * Factor 118.7 32.1 <0.001 
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but the corresponding long-term outcomes have 
hardly enhanced (9). Chronic renal transplant 
dysfunction is among the most common reasons 
leading to graft loss, which is evaluated by measuring 
kidney function over time. Several studies have been 
conducted to evaluate short-term and long-term 
performance of transplant. In these studies, the 
function of the kidneys is evaluated through clinical 
indices such as serum creatinine, glomerular filtration 
rate, and creatinine clearance. Moreover, the slope of 
the regression line of each of the above indices is 
determined, in terms of time, as the rate of 
progression in the transplant population and the 
patients with chronic kidney disease (10-12). In this 
study, to investigate the performance of transplant 
allograft within 7 days from the transplantation, the 
metabolic acidosis factor and its impact on the 
transplant outcome have been taken into account with 
emphasis on immune factors associated with 
transplant rejection besides the factors mentioned 
above.  
Metabolic acidosis, occurring because of 
reduced serum concentrations of CO2, can have 
adverse effects leading to rejection, depending on the 
patient's condition and the type of transplant. In a 
study conducted by Park et al, there was reported a 
risk of rejection following the increased serum 
concentrations of CO2 at approximately 74 (13). In 
various studies, the prevalence of metabolic acidosis 
in kidney transplant patients was reported even up to 
58 percent, and it is essential to address it considering 
the effects of this phenomenon on the outcome of 
kidney transplantation (14). Acidosis in kidney 
transplant patients is particularly important because, 
in addition to adverse effects on the hemodynamic 
system, it increases the production of cytokines and 
the activity of neutrophils in the body, which is 
ultimately detrimental to the transplant (15). 
Similarly, certain studies have addressed the role of 
post-transplant acidosis in mineral metabolism 
disorder in the body and its effect on the outcome of 
transplantation (14). 
The present study suggests that short-term 
treatment of acidosis with bicarbonate sodium in the 
intervention group (compared to control group) leads 
to a reduction in BUN serum concentration with a 
coefficient of -0.25 within seven days after the 
transplantation, indicating the proper functioning 
allograft in this period. It should be noted that 
monitoring of metabolic acidosis in patients with 
ESRD should be done on a regular basis at least 1 
year after transplantation. It important in order to 
maintain serum concentrations of CO2 higher than 21 
mEq/l, because the interaction of various factors such 
as metabolic acidosis caused by improper functioning 
of allograft, immune factors related to transplantation 
and the patient's condition may lead to acute rejection 
(16, 17). The results also suggest that treatment of 
acidosis does not significantly increase creatinine 
clearance in the intervention group compared to the 
control group and that both groups gradually 
witnessed an increase in clearance. However, in this 
study, reduced serum creatinine was not helpful in the 
treatment of metabolic acidosis, which is not the case 
for the studies by other researchers (18). The present 
study shows that the cytokines IFN-γ and interleukin 
2 underwent a reduction after the treatment and 
correction of metabolic acidosis in patients while IL-
10 began increasing. The study by Ori et al. 
evaluating the effects of correction of acidosis on 
cytokine secretion in patients with chronic kidney 
problem showed that the treatment of acidosis in 
CKD patients leads to decrease desecration of IL-10 
but other chemokine including IL-1 β, IL-2, IL-6, 
TNF α, IFN γ, IL-1ra did not change significantly 
compared to before the transplant (19). In other study 
Table 4: Results of GEE model on evaluating the effects of acidosis treatment on immunological factors. 
 
Outcomes Variables Coefficient,% 95 CI P-value 
IFN-γ Group -1.74 (-3.09, -0.39) 0.011 
Time -0.44 (-1.04, -0.03) 0.033 
IL-2 Group -1.37 (-2.57, -0.17) 0.025 
Time -0.45 (-0.89, -0.004) 0.048 
IL-10 Group 2.85 (1.29, 4.41) <0.001 
Time 0.65 (0.01, 1.31) 0.044 
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on chronic antibody-mediated rejection and improper 
performance of allograft, it was shown that in this 
type of patients, the graft survival can greatly improve 
simply by regulating the IFNγ secretion (20). 
The present study clearly demonstrates that 
treatment of metabolic acidosis in kidney transplant 
patients during anesthesia within seven days after 
transplantation leads to improved outcome of a 
transplant by reducing the secretion of IL-2 and 
Interferon Gamma. It should be noted, however, that 
the outcome of transplant is not affected by treatment 
of renal tubular acidosis alone and that 
 
Figure 2. The changes of serum creatinine and BUN during seven days after kidney transplant. 
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immunosuppressive regimen, immune factors, 
personal characteristics and type of the graft are all 
effective in transplant rejection (17). For example, in 
a study on the effects of Interferon Gamma on the 
outcome, the researchers recommended that Pre-
transplant determination of the numbers of IFN-γ-
producing donor-specific memory cells be performed 
to predict acute rejection of transplanted cells and 
then the transplantation be carried out (21). 
Despite the fact that metabolic acidosis is a 
common problem in kidney transplantation and can 
have negative effects, there is little information on 
 
Figure 3. Change pattern of IL-2 and IL-10 during seven days after kidney transplantation. 
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this topic (22). The first issue is lack of awareness 
about the exact prevalence of acidosis in kidney 
transplant patients and how it changes over time. The 
second issue is that there are not still extensive studies 
with sufficient sample size to make sure that the 
patients benefit from the correction of this disorder. 
The other issue is the uncertainty as to what extent of 
Acidosis should undergo treatment and what the ideal 
stage of this treatment is. Among the strengths of the 
present study is that it is the first to have addressed 
the effect of Acidosis correction on the outcome of 
kidney transplantation in patients. Although the 
results clearly suggest that correction of acidosis in 
renal transplant patients during surgery helps improve 
the performance of allograft in the short run, it is 
recommended that more extensive studies are carried 
out taking into account the long-term and short-term 
effects of this intervention and its cost-effectiveness 
for full investigation of the various aspects of 
correction of metabolic acidosis in kidney transplant 
patients. 
Conclusion 
Although the results clearly suggest that 
correction of acidosis in renal transplant patients 
during surgery helps improve the performance of 
allograft in the short run, but it is recommended that 
more studies be carried out taking into account the 
long-term and short-term effects of this intervention. 
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